This article or section is written like an advertisement. Please help rewrite this article from a neutral point of view. Mark blatant advertising for speedy deletion, using {{db-spam}}.

Novo Nordisk A/S
Type	Public (OMX: NOVO B, NYSE: NVO)
Founded	1923
Headquarters	Bagsværd, Denmark
Key people	Sten Scheibye, Chairman Lars Rebien Sørensen, President & CEO Jesper Brandgaard, CFO
Industry	Pharmaceuticals, Healthcare
Products	Activelle, Levemir, NovoSeven
Revenue	38.743 billion DKK or $6.9 billion USD (2006) [1]
Employees	23,172 (2006)
Website	www.novonordisk.com

Novo Nordisk (OMX: NOVO B, NYSE: NVO) manufactures and markets pharmaceutical products and services. Founded in Denmark in 1923, the company has since become a world leader in diabetes care with one of the broadest diabetes product portfolios in the industry, including the products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position in areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Image File history File links Emblem-important. ... Shortcut: WP:WIN Wikipedia is an online encyclopedia and, as a means to that end, also an online community. ... Shortcut: WP:CSD Current list: Category:Candidates for speedy deletion There are a few, limited, cases where admins can delete Wikipedia pages on sight. Non-admins can ask for an admin to delete such a page, either by listing it on speedy deletions, or by adding either a {{delete}} or... Image File history File linksMetadata NovoNordisk. ... This article does not cite any references or sources. ... OMX AB is a Swedish-Finnish financial services company, formed in 2003 through a merger between OM AB and HEX plc. ... The New York Stock Exchange (NYSE), nicknamed the Big Board, is a New York City-based stock exchange. ... Year 1923 (MCMXXIII) was a common year starting on Monday (link will display the full calendar) of the Gregorian calendar. ... Pharmacology (in Greek: pharmacon is drug, and logos is science) is the study of how chemical substances interfere with living systems. ... Health care or healthcare is one of the worlds largest and fastest growing professions. ... Levemir (insulin detemir) is a basal insulin analogue created by Novo Nordisk. ... Look up revenue in Wiktionary, the free dictionary. ... Green up arrow for a positive change in revenue from last fiscal year. ... Danish coins The Danish krone is the currency used in Denmark and the Danish dependency of Greenland. ... USD redirects here. ... Year 2006 (MMVI) was a common year starting on Sunday of the Gregorian calendar. ... This article is about work. ... A website (alternatively, Web site or web site) is a collection of Web pages, images, videos or other digital assets that is hosted on one or several Web server(s), usually accessible via the Internet, cell phone or a LAN. A Web page is a document, typically written in HTML... OMX AB is a Swedish-Finnish financial services company, formed in 2003 through a merger between OM AB and HEX plc. ... The New York Stock Exchange (NYSE), nicknamed the Big Board, is a New York City-based stock exchange. ... Pharmacology (in Greek: pharmacon is drug, and logos is science) is the study of how chemical substances interfere with living systems. ... Year 1923 (MCMXXIII) was a common year starting on Monday (link will display the full calendar) of the Gregorian calendar. ... This article is about the disease that features high blood sugar. ... is really just water but doctors get you to pay more Not to be confused with inulin. ... Hemostasisis the physiologic process which results in the cessation of bleeding in most animals with a closed circulatory system. ... Growth hormone (GH) or somatotropin (STH) is a protein hormone which stimulates growth and cell reproduction in humans and other animals. ... Hormone replacement therapy (HRT) is a system of medical treatment for perimenopausal and postmenopausal women, based on the assumption that it may prevent discomfort and health problems caused by diminished circulating estrogen hormones. ...

With headquarters in Denmark, Novo Nordisk has production facilities in six countries, with affiliates or offices in 68 countries. Novo Nordisk employs 23,172 people globally (as of 2006) [2]. Year 2006 (MMVI) was a common year starting on Sunday of the Gregorian calendar. ...

Novo Nordisk claims to be dedicated to developing its business towards ecological, social and economic sustainability. The company says this commitment is demonstrated through its values and its environmental and social responsibility policies also called the triple bottom-line, although some question the authenticity of this given the company's aggressive pursuit of profits.

Company Logo

The Novo Nordisk logo is the Apis bull, one of the sacred animals of ancient Egypt. The Apis bull was worshipped as the incarnation of Ptah, creator of the universe, city god of Memphis and the patron deity of craftsmen.

The logo is a stylised reproduction of an Egyptian statuette dating from circa 664–323 BC. It is richly ornamented with symbols representing, among other things, the eternal dualities of life, day and night, life and death.

The Apis bull has been Novo’s logo since the year after the company’s foundation. The choice of the logo follows an old European chemist's tradition of identifying pharmacies by an animal symbol.

Unite for Diabetes

Novo Nordisk A/S is a firm follower of the 'triple bottom line'. As part of this ideal, as well as being a global leader in Diabetes care, Novo Nordisk have sponsored the International Diabetes Federation's Unite for Diabetes campaign — a campaign that has successfully achieved a UN Resolution on Diabetes.

As such, they have also launched the Novo Nordisk Changing Diabetes World Tour — a truck that folds out into an educational and awareness-developing bus. The vehicle was launched in Copenhagen in September 2005 and has visited Europe, Africa, and Australia.

Timeline

Novo Nordisk was created in 1989 through a merger between two Danish companies – Novo Industri A/S and Nordisk Gentofte A/S.

• 1923 Nordisk Insulinlaboratorium (later Nordisk Gentofte) founded.
• 1925 Novo Terapeutisk Laboratorium (later Novo Industri) founded.
• 1932 Nordisk Insulinlaboratorium founds the Steno Memorial Hospital.
• 1938 Novo founds Hvidøre Diabetes Sanatorium.
• 1941 Novo launches its first enzyme, trypsin, extracted from the pancreas of animals and used for bating leather before tanning.
• 1946 Nordisk develops Isophane insulin NPH insulin, a neutral insulin with prolonged action.
• 1947 Penicillin Novo is launched – Novo’s first product to be manufactured through fermentation.
• 1953 Lente® – a long-acting insulin zinc suspension – is launched.
• 1963 Alcalase® – Novo’s first detergent enzyme produced by fermentation.
• 1973 Nordisk Gentofte markets Nanormon® growth hormone for the treatment of growth hormone insufficiency. The growth hormone is extracted from human pituitary glands.
• 1973 Monocomponent (MC) insulin is introduced – the purest insulin available.
• 1974 Novo’s B shares are quoted on the Copenhagen Stock Exchange.
• 1977 Trisequens® – sequential combined oral hormone replacement therapy (HRT) for peri-menopausal women – is marketed.
• 1981 Novo becomes the first company in Scandinavia to be quoted on the New York Stock Exchange.
• 1982 Human Monocomponent insulin is launched – the world’s first insulin preparation identical to human insulin. It is extracted from the pancreas of pigs and converted to human insulin.
• 1985 NovoPen® – an injection system similar in appearance to a fountain pen, with replaceable insulin cartridges – is launched.
• 1987 Novo starts production of human insulin with the help of genetically engineered yeast cells.
• 1988 Nordisk Gentofte markets Norditropin® genetically engineered human growth hormone.
• 1989 Novo Industri A/S and Nordisk Gentofte A/S merge to become the world’s leading producer of insulin.
• 1989 NovoLet® – the world’s first prefilled insulin syringe – is marketed.
• 1992 The Steno Memorial Hospital and Hvidøre Hospital merge to form the Steno Diabetes Center.
• 1994 Novo Nordisk is the first company in Denmark – and one of the first in the world – to publish an environmental report.
• 1996 NovoSeven® – for the treatment of haemophilia patients with inhibitor reaction – is launched.
• 1998 NovoNorm®/Prandin®, a new oral treatment for type 2 diabetes, is launched in the US and a number of European countries.
• 1998 Activelle® – the first low-dose continuous combined oral HRT for post-menopausal women – is introduced.
• 1999 Novo Nordisk publishes its first social report.
• 1999 Innovo®, the world’s first insulin doser with a built-in electronic memory, is launched in Europe.
• 1999 NovoRapid® (NovoLog® in the US) – a rapid-acting insulin analogue – is marketed.
• 1999 Norditropin® SimpleXx® – the world’s first liquid growth hormone in a dedicated pen system – is launched.
• 2000 Novofem®, a low-dose sequential combined oral HRT, is marketed in Germany. Two years later it is launched in several other European countries.
• 2000 Novo Nordisk is split into three separate companies operating under the umbrella of the Novo Group: Novo Nordisk A/S, Novozymes A/S and Novo A/S.
• 2001 InnoLet® – the first insulin delivery system specially designed to suit the needs of insulin users with poor eyesight and reduced dexterity – is launched.
• 2001 InDuo® – the world’s first combined blood glucose monitor and insulin injection system – is introduced.
• 2001 NovoRapid® FlexPen® and Insulatard® (NPH) FlexPen® are marketed. FlexPen® is a new prefilled pen, designed to be easy and discreet to use.
• 2001 Novo Nordisk acquires the controlling interest in the Brazilian pharmaceutical company Biobrás.
• 2002 NovoMix® 30 FlexPen® and NovoMix® Penfill® are introduced. NovoMix® 30 is a dual-release insulin analogue.
• 2004 Levemir® – a long-acting insulin analogue – is launched.

Hans Christian Hagedorn (1888-1971) Neutral Protamine Hagedorn was created in 1946 when Nordisk formulated isophane porcine insulin by adding Neutral Protamine Hagedorn or NPH. History Hans Christian Hagedorn (1888-1971) and August Krogh (1874-1949) obtained the rights for insulin from Banting and Best in Toronto. ... Repaglinide (Prandin® in the US, GlucoNorm® in Canada, NovoNorm® elsewhere) is a for the treatment of type II diabetes. ... Novozymes (CSE: NZYM-B) is a biotech-based company and the world’s largest producer of industrial enzymes and microorganisms, with a market share of approximately 46% for enzymes and approximately 50% for microorganisms (2006)[1]. The company’s products are used in more than 40 different industries to improve...

See also

• Novo Nordisk Servicepartner
• Novo Nordisk Engineering
• NNIT (formerly Novo Nordisk IT)

NNE is wholly owned by Novo Nordisk, which was founded as a consultancy engineering company in the 1920s. ... NNIT A/S is a daughter company of Novo Nordisk and primary supplier of IT services for Novo Nordisk. ...

External links

• Novo Nordisk Website
  
• Novo Nordisk Changing Diabetes World Tour
• Novozymes A/S Website
• NNIT Website
• Novo Nordisk Servicepartner A/S Website
• NNE Website
• Novo A/S Website
• Novo Nordisk Foundation Website
• Novo Nordisk Biotech Fund Website

v • d • e OMX Copenhagen 20 companies of Denmark

A.P. Møller-Maersk · Carlsberg · Coloplast · Dampskibsselskabet TORM · Danisco · Danske Bank · DSV · FLSmidth & Co. · GN Store Nord · Genmab · Lundbeck · Nordea · Novo Nordisk · Novozymes · Sydbank · Topdanmark · TrygVesta · Vestas Wind Systems · William Demant Image File history File links Flag_of_Denmark. ... The OMX Copenhagen 20 (OMXC20, formerly KFX) is the top-tier stock market index for the Copenhagen Stock Exchange, which is part of the OMX group. ... The A.P. Moller-Maersk Group (Danish: A.P. Møller-Mærsk Gruppen) is an international business conglomerate involved in a variety of business sectors, primarily transportation. ... Note: Carling beer is not produced by the Carlsberg brewery. ... A/S Dampskibsselskabet TORM or TORM (NYSE: TRMD), based in Copenhagen, Denmark, is a shipping company that owns and operates product tankers and bulk carriers. ... This article or section does not cite any references or sources. ... This article does not cite any references or sources. ... DSV is as a global supplier of transport and logistics services. ... H. Lundbeck A/S (also known as Lundbeck) is a Danish international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. ... Nordea is a financial services group operating in Northern Europe, based in Stockholm. ... Novozymes (CSE: NZYM-B) is a biotech-based company and the world’s largest producer of industrial enzymes and microorganisms, with a market share of approximately 46% for enzymes and approximately 50% for microorganisms (2006)[1]. The company’s products are used in more than 40 different industries to improve... Vestas is a Danish company that designs, manufactures, and sells wind turbines. ... The William Demant Holding Group is a leading international hearing health care company within hearing aids, audiometric equipment, and personal communication. ...